Prussian Blue Therapy

Prussian Blue Therapy is a medical treatment modality that employs the administration of Prussian blue, a ferric hexacyanoferrate compound, to enhance the elimination of thallium through enterohepatic recirculation interruption by binding thallium in the gastrointestinal tract.

171

Publications

9.7K

Citations

1.1K

Authors

331

Institutions

Publications per year

2017–2026

108

Variants

Prussian Blue Treatment

Authors

1.1K

  1. XC
    Xiaojun Cai

    Shanghai Jiao Tong University, China

    10 publications · 1.4K citations

    10

    h-index

  2. WG
    Wei Gao

    Shanghai Jiao Tong University, China

    7 publications · 979 citations

    7

    h-index

  3. RF
    Rohan Fernandes

    George Washington University, United States

    7 publications · 625 citations

    7

    h-index

  4. BL
    Bin Liu

    Hunan University, China

    6 publications · 362 citations

    6

    h-index

  5. JF
    Jialong Fan

    Hunan University, China

    5 publications · 339 citations

    5

    h-index

1–5 of 1.1K

Venues

  1. Journal of Materials Chemistry B

    9 publications · 346 citations

    9

    h-index

  2. Health Physics

    7 publications · 189 citations

    7

    h-index

  3. Journal of Toxicology Clinical Toxicology

    7 publications · 165 citations

    7

    h-index

  4. ACS Nano

    7 publications · 723 citations

    7

    h-index

  5. PubMed

    Repository · 6 publications · 179 citations

    6

    h-index

1–5